These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11751017)

  • 41. [Antiamnesic activity of nerve growth factor adsorbed on poly(butyl) cyanoacrylate nanoparticles coated with polysorbate-80].
    Basel AA; Petrov VE; Trofimov SS; Voronina TA; Aliautdin RN
    Eksp Klin Farmakol; 2005; 68(6):3-8. PubMed ID: 16405025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles.
    Zhang Y; Yu J; Zhang L; Cai J; Cai D; Lv C
    Tumour Biol; 2016 Feb; 37(2):2703-8. PubMed ID: 26404136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo.
    Kolter M; Ott M; Hauer C; Reimold I; Fricker G
    J Control Release; 2015 Jan; 197():165-79. PubMed ID: 25445700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma.
    Whittle JR; Lickliter JD; Gan HK; Scott AM; Simes J; Solomon BJ; MacDiarmid JA; Brahmbhatt H; Rosenthal MA
    J Clin Neurosci; 2015 Dec; 22(12):1889-94. PubMed ID: 26279503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles.
    Maksimenko O; Pavlov E; Toushov E; Molin A; Stukalov Y; Prudskova T; Feldman V; Kreuter J; Gelperina S
    Int J Pharm; 2008 May; 356(1-2):325-32. PubMed ID: 18295418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury.
    Zhao LX; Liu AC; Yu SW; Wang ZX; Lin XQ; Zhai GX; Zhang QZ
    Biol Pharm Bull; 2013; 36(8):1263-70. PubMed ID: 23902970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation.
    Mühlstein A; Gelperina S; Shipulo E; Maksimenko O; Kreuter J
    Pharmazie; 2014 Jul; 69(7):518-24. PubMed ID: 25073397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The delivery of loperamide to the brain by using polybutyl cyanoacrylate nanoparticles].
    Aliautdin RN; Petrov VE; Langer K; Berthold A; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 1998; 61(1):17-20. PubMed ID: 9575405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
    Alyautdin RN; Tezikov EB; Ramge P; Kharkevich DA; Begley DJ; Kreuter J
    J Microencapsul; 1998; 15(1):67-74. PubMed ID: 9463808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Drug delivery to the brain with nanoparticles].
    Aliautdin RN; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 2003; 66(2):65-8. PubMed ID: 12962052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
    Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS
    J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Alyautdin RN; Petrov VE; Langer K; Berthold A; Kharkevich DA; Kreuter J
    Pharm Res; 1997 Mar; 14(3):325-8. PubMed ID: 9098875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In Vivo Anticancer Efficacy and Toxicity Studies of a Novel Polymer Conjugate N-Acetyl Glucosamine (NAG)-PEG-Doxorubicin for Targeted Cancer Therapy.
    Pawar S; Mahajan K; Vavia P
    AAPS PharmSciTech; 2017 Nov; 18(8):3021-3033. PubMed ID: 28497240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate.
    Capelôa T; Caramelo F; Fontes-Ribeiro C; Gomes C; Silva AP
    Neurotox Res; 2014 Oct; 26(3):216-27. PubMed ID: 24652521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preclinical evaluation of the cardiotoxicity of PK2: a novel HPMA copolymer-doxorubicin-galactosamine conjugate antitumour agent.
    Hopewel JW; Duncan R; Wilding D; Chakrabarti K
    Hum Exp Toxicol; 2001 Sep; 20(9):461-70. PubMed ID: 11776408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages.
    Soma CE; Dubernet C; Barratt G; Nemati F; Appel M; Benita S; Couvreur P
    Pharm Res; 1999 Nov; 16(11):1710-6. PubMed ID: 10571276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Body distribution of 3H-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after i.v. injections to mice.
    Schroeder U; Schroeder H; Sabel BA
    Life Sci; 2000; 66(6):495-502. PubMed ID: 10794066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fullerenol nanoparticles prevents doxorubicin-induced acute hepatotoxicity in rats.
    Jacevic V; Djordjevic A; Srdjenovic B; Milic-Tores V; Segrt Z; Dragojevic-Simic V; Kuca K
    Exp Mol Pathol; 2017 Apr; 102(2):360-369. PubMed ID: 28315688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.